Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Use of oral vasopressin V2 receptor antagonist for hyponatremia in acute brain injury.

Jeon SB, Choi HA, Lesch C, Kim MC, Badjatia N, Claassen J, Mayer SA, Lee K.

Eur Neurol. 2013;70(3-4):142-8. doi: 10.1159/000350844. Epub 2013 Jul 25. No abstract available.

PMID:
23887035
[PubMed - indexed for MEDLINE]
Free Article
2.

Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury.

Human T, Onuoha A, Diringer M, Dhar R.

J Crit Care. 2012 Dec;27(6):745.e1-5. doi: 10.1016/j.jcrc.2012.03.003. Epub 2012 Apr 18.

PMID:
22520494
[PubMed - indexed for MEDLINE]
3.

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C; SALT Investigators.

N Engl J Med. 2006 Nov 16;355(20):2099-112. Epub 2006 Nov 14.

PMID:
17105757
[PubMed - indexed for MEDLINE]
Free Article
4.

A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.

Dhar R, Murphy-Human T.

Neurocrit Care. 2011 Feb;14(1):97-102. doi: 10.1007/s12028-010-9366-x.

PMID:
20440600
[PubMed - indexed for MEDLINE]
5.

[Vasopressin antagonist in hyponatremia. Rapid and simple control of serum sodium concentration].

[No authors listed]

MMW Fortschr Med. 2012 Dec 17;154(22):78-9. German. No abstract available.

PMID:
23297546
[PubMed - indexed for MEDLINE]
6.

Tolvaptan and hyponatremia in a patient with cirrhosis.

Boyer TD.

Hepatology. 2010 Feb;51(2):699-702. doi: 10.1002/hep.23522. No abstract available.

PMID:
20101750
[PubMed - indexed for MEDLINE]
7.

Management of hyponatremia and clinical use of vasopressin antagonists.

Oh MS.

Am J Med Sci. 2007 Feb;333(2):101-5. Review.

PMID:
17301588
[PubMed - indexed for MEDLINE]
8.

Vasopressin V2-receptor antagonists: panaceas for hyponatremia?

Kitiyakara C, Wilcox CS.

Curr Opin Nephrol Hypertens. 1997 Sep;6(5):461-7. Review. Erratum in: Curr Opin Nephrol Hypertens 1998 May;7(3):353.

PMID:
9327205
[PubMed - indexed for MEDLINE]
9.

AVP receptor antagonists in patients with CHF.

Kumar SK, Mather PJ.

Heart Fail Rev. 2009 Jun;14(2):83-6. doi: 10.1007/s10741-008-9107-9. Epub 2008 Sep 3. Review.

PMID:
18766439
[PubMed - indexed for MEDLINE]
10.

Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.

Madias NE.

Am J Kidney Dis. 2007 Aug;50(2):184-7. Review. No abstract available.

PMID:
17660019
[PubMed - indexed for MEDLINE]
11.

[Vasopressin receptor antagonists: the vaptans].

Villabona C.

Endocrinol Nutr. 2010 May;57 Suppl 2:41-52. doi: 10.1016/S1575-0922(10)70021-8. Review. Spanish.

PMID:
21130961
[PubMed - indexed for MEDLINE]
12.

Tolvaptan for hyponatremia.

Dawwas MF.

N Engl J Med. 2007 Mar 1;356(9):961-2; author reply 962-3. No abstract available.

PMID:
17338051
[PubMed - indexed for MEDLINE]
13.

Vasopressin receptor antagonist use in a neurologic rehabilitation center.

Garrett RE, Wilhelm S, Maerz G, Bar-Or D.

J Spinal Cord Med. 2010;33(1):65-7.

PMID:
20397445
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.

Gargani L, Schmidt PH, Gheorghiade M.

Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1505-13. doi: 10.1586/erc.11.163. Review.

PMID:
22103869
[PubMed - indexed for MEDLINE]
15.

Tolvaptan for hyponatremia.

Hoorn EJ, Zietse R.

N Engl J Med. 2007 Mar 1;356(9):961; author reply 962-3. No abstract available.

PMID:
17338052
[PubMed - indexed for MEDLINE]
16.

[Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].

Foppiani L, Raggi F, Tagliabue M, Benso A, Brandolin I, Lo Pinto G.

Recenti Prog Med. 2013 Mar;104(3):112-5. doi: 10.1701/1255.13859. Italian.

PMID:
23548955
[PubMed - indexed for MEDLINE]
17.

Tolvaptan for hyponatremia.

Ozkan C, Kirkpantur A, Arici M.

N Engl J Med. 2007 Mar 1;356(9):962; author reply 962-3. No abstract available.

PMID:
17338053
[PubMed - indexed for MEDLINE]
18.

Tolvaptan for hyponatremia.

Weise WJ, Rimmer JM, Hood VL.

N Engl J Med. 2007 Mar 1;356(9):961; author reply 962-3. No abstract available.

PMID:
17329708
[PubMed - indexed for MEDLINE]
Free Article
19.

[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].

Yamamura Y, Sato O, Fujiki H.

Nihon Rinsho. 2007 May 28;65 Suppl 5:164-8. Review. Japanese. No abstract available.

PMID:
17571379
[PubMed - indexed for MEDLINE]
20.

Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.

Schrier RW, Masoumi A, Elhassan E.

Blood Purif. 2009;27(1):28-32. doi: 10.1159/000167005. Epub 2009 Jan 23. Review.

PMID:
19169014
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk